These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

77 related items for PubMed ID: 2479330

  • 1. Prophylactic antiangiogenic tumor treatment.
    Madarnas P, Benrezzak O, Nigam VN.
    Anticancer Res; 1989; 9(4):897-901. PubMed ID: 2479330
    [Abstract] [Full Text] [Related]

  • 2. Effect of maltose tetrapalmitate on tumor vascularization and tumor growth.
    Benrezzak O, Bissonnette E, Madarnas P, Nigam VN.
    Anticancer Res; 1989; 9(6):1815-8. PubMed ID: 2483306
    [Abstract] [Full Text] [Related]

  • 3. Evaluation of cortisone-heparin and cortisone-maltose tetrapalmitate therapies against rodent tumors. I. Biological studies.
    Benrezzak O, Madarnas P, Pageau R, Nigam VN, Elhilali MM.
    Anticancer Res; 1989; 9(6):1883-7. PubMed ID: 2627134
    [Abstract] [Full Text] [Related]

  • 4. Evaluation of cortisone-heparin and cortisone-maltose tetrapalmitate therapies against rodent tumors. II. Pathological studies.
    Madarnas P, Benrezzak O, Pageau R, Nigam VN, Elhilali M.
    Anticancer Res; 1989; 9(6):1889-95. PubMed ID: 2627135
    [Abstract] [Full Text] [Related]

  • 5. Interleukin-12 inhibits angiogenesis and growth of transplanted but not in situ mouse mammary tumor virus-induced mammary carcinomas.
    Lee JC, Kim DC, Gee MS, Saunders HM, Sehgal CM, Feldman MD, Ross SR, Lee WM.
    Cancer Res; 2002 Feb 01; 62(3):747-55. PubMed ID: 11830529
    [Abstract] [Full Text] [Related]

  • 6. An antiangiogenic urokinase-derived peptide combined with tamoxifen decreases tumor growth and metastasis in a syngeneic model of breast cancer.
    Guo Y, Mazar AP, Lebrun JJ, Rabbani SA.
    Cancer Res; 2002 Aug 15; 62(16):4678-84. PubMed ID: 12183425
    [Abstract] [Full Text] [Related]

  • 7. Antiangiogenic treatment enhances photodynamic therapy responsiveness in a mouse mammary carcinoma.
    Ferrario A, von Tiehl KF, Rucker N, Schwarz MA, Gill PS, Gomer CJ.
    Cancer Res; 2000 Aug 01; 60(15):4066-9. PubMed ID: 10945611
    [Abstract] [Full Text] [Related]

  • 8. Adenovirus-mediated gene transfer of endostatin in vivo results in high level of transgene expression and inhibition of tumor growth and metastases.
    Sauter BV, Martinet O, Zhang WJ, Mandeli J, Woo SL.
    Proc Natl Acad Sci U S A; 2000 Apr 25; 97(9):4802-7. PubMed ID: 10758166
    [Abstract] [Full Text] [Related]

  • 9. Inhibition of antitumor effects of flavone acetic acid by cortisone.
    Ching LM, Joseph WR, Baguley BC.
    Anticancer Res; 1993 Apr 25; 13(4):1139-41. PubMed ID: 8352536
    [Abstract] [Full Text] [Related]

  • 10. Aerosol delivery of liposomal formulated paclitaxel and vitamin E analog reduces murine mammary tumor burden and metastases.
    Latimer P, Menchaca M, Snyder RM, Yu W, Gilbert BE, Sanders BG, Kline K.
    Exp Biol Med (Maywood); 2009 Oct 25; 234(10):1244-52. PubMed ID: 19657067
    [Abstract] [Full Text] [Related]

  • 11. Induction of antitumor immunity employing live tumor cells and maltose tetrapalmitate.
    Bonaventure J, Nigam VN, Brailovsky CA.
    J Biol Response Mod; 1985 Jun 25; 4(3):258-63. PubMed ID: 4020385
    [Abstract] [Full Text] [Related]

  • 12. Antiangiogenic and antitumor activities of peptide inhibiting the vascular endothelial growth factor binding to neuropilin-1.
    Starzec A, Vassy R, Martin A, Lecouvey M, Di Benedetto M, Crépin M, Perret GY.
    Life Sci; 2006 Nov 17; 79(25):2370-81. PubMed ID: 16959272
    [Abstract] [Full Text] [Related]

  • 13. Flavopiridol increases therapeutic ratio of radiotherapy by preferentially enhancing tumor radioresponse.
    Mason KA, Hunter NR, Raju U, Ariga H, Husain A, Valdecanas D, Neal R, Ang KK, Milas L.
    Int J Radiat Oncol Biol Phys; 2004 Jul 15; 59(4):1181-9. PubMed ID: 15234054
    [Abstract] [Full Text] [Related]

  • 14. Combined therapy of local and metastatic 4T1 breast tumor in mice using SU6668, an inhibitor of angiogenic receptor tyrosine kinases, and the immunostimulator B7.2-IgG fusion protein.
    Huang X, Wong MK, Yi H, Watkins S, Laird AD, Wolf SF, Gorelik E.
    Cancer Res; 2002 Oct 15; 62(20):5727-35. PubMed ID: 12384531
    [Abstract] [Full Text] [Related]

  • 15. ZD6126: a novel vascular-targeting agent that causes selective destruction of tumor vasculature.
    Davis PD, Dougherty GJ, Blakey DC, Galbraith SM, Tozer GM, Holder AL, Naylor MA, Nolan J, Stratford MR, Chaplin DJ, Hill SA.
    Cancer Res; 2002 Dec 15; 62(24):7247-53. PubMed ID: 12499266
    [Abstract] [Full Text] [Related]

  • 16. CEP-7055: a novel, orally active pan inhibitor of vascular endothelial growth factor receptor tyrosine kinases with potent antiangiogenic activity and antitumor efficacy in preclinical models.
    Ruggeri B, Singh J, Gingrich D, Angeles T, Albom M, Yang S, Chang H, Robinson C, Hunter K, Dobrzanski P, Jones-Bolin S, Pritchard S, Aimone L, Klein-Szanto A, Herbert JM, Bono F, Schaeffer P, Casellas P, Bourie B, Pili R, Isaacs J, Ator M, Hudkins R, Vaught J, Mallamo J, Dionne C.
    Cancer Res; 2003 Sep 15; 63(18):5978-91. PubMed ID: 14522925
    [Abstract] [Full Text] [Related]

  • 17. Therapeutic electromagnetic field effects on angiogenesis and tumor growth.
    Williams CD, Markov MS, Hardman WE, Cameron IL.
    Anticancer Res; 2001 Sep 15; 21(6A):3887-91. PubMed ID: 11911264
    [Abstract] [Full Text] [Related]

  • 18. Protease activity of urokinase and tumor progression in a syngeneic mammary cancer model.
    Merchan JR, Tang J, Hu G, Lin Y, Mutter W, Tong C, Karumanchi SA, Russell SJ, Sukhatme VP.
    J Natl Cancer Inst; 2006 Jun 07; 98(11):756-64. PubMed ID: 16757700
    [Abstract] [Full Text] [Related]

  • 19. Combined cyclophosphamide chemotherapy and maltose tetrapalmitate immunotherapy in the treatment of transplanted bladder and prostate carcinoma of the rat.
    Ibrahiem EH, Nigam VN, Brailovsky CA, Backman BD, Elhilali MM.
    Cancer Res; 1984 Feb 07; 44(2):536-42. PubMed ID: 6537897
    [Abstract] [Full Text] [Related]

  • 20. The novel tubulin-binding drug BTO-956 inhibits R3230AC mammary carcinoma growth and angiogenesis in Fischer 344 rats.
    Shan S, Lockhart AC, Saito WY, Knapp AM, Laderoute KR, Dewhirst MW.
    Clin Cancer Res; 2001 Aug 07; 7(8):2590-6. PubMed ID: 11489843
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.